About APCI

APCI logo

Not a member?
Join today!

(800) 532-2724

Since 1984, APCI has been the ‘united voice of independent pharmacy’

APCI began as a small buying group for a limited number of independent pharmacies in central Alabama. Since that time, the cooperative has grown to more than 1,800 members pharmacies in 26 states, and provides its members with a wide range of products and services.

Our mission is to represent the economic and professional interests of independent pharmacies by providing leadership, vision, and a collective voice for our members in the healthcare marketplace. Our goal is to level the playing field for our member pharmacies by providing innovative, targeted programs to benefit our entire membership.

10

Apr

2017

Argus : Change in Nebulizer Processing – Part B vs. Part D Status

BIN: 012353 PCN: 05650000

According to CMS guidance, as described in Chapter 6 of the Drug Benefit Manual, "drugs billed by pharmacy suppliers and administered through durable medical equipment (DME), such as respiratory drugs given through a nebulizer" are covered under Part B.

10

Apr

2017

CVS Caremark Part D: SilverScript - Formulary Update

BIN: 004336 PCN: MEDDADV Group: RXCVSD

SilverScript may add or remove drugs from our formulary during the year.

7

Apr

2017

CVS Caremark : Caremark Medicare Part D

Effective April 1, 2017

CVS Caremark Medicare Part D Services may add or remove drugs from our formulary during the year.

7

Apr

2017

CVS Caremark : Medicare Part D Providers Appropriate Days Supply

The Centers for Medicare and Medicaid Services (CMS) require all Medicare Part D claims submitted with a Patient Residence code of 03 (Nursing Facility) to apply the appropriate dispensing requirements as stated in 42 CFR § 423.154(a)(1)(i), regardless of the pharmacy service type. This requirement states brand oral solid medications for Medicare Part D beneficiaries in a Long-term Care facility must be dispensed in 14-day supply or less increments.

7

Apr

2017

Envolve Pharmacy Solutions: URGENT FDA NOTICE - GlaxoSmithKline is Recalling more than a half Million Ventolin HFA 200 Asthma Inhalers

***URGENT FDA NOTICE***

Please see the attached information regarding the, GlaxoSmithKline is Recalling more than a half Million Ventolin HFA 200 Asthma Inhalers
First 462463464465 Last